Literature DB >> 17406150

Hypocitraturia despite potassium citrate tablet supplementation.

Chetan Shenoy1.   

Abstract

Citrate supplementation is widely used in the prevention of recurrent nephrolithiasis with hypocitraturia. Potassium citrate is the most commonly used citrate agent for this indication. In patients with chronic diarrheal syndromes, the absorption of potassium citrate can be affected. We describe a patient who presented with recurrent nephrolithiasis and chronic diarrhea and was found to have severe hypocitraturia despite citrate supplementation with potassium citrate tablets, likely due to inadequate gastrointestinal absorption of citrate from the slow-release wax-matrix tablets.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17406150      PMCID: PMC1781310     

Source DB:  PubMed          Journal:  MedGenMed        ISSN: 1531-0132


  12 in total

Review 1.  Pathophysiology of hypocitraturic nephrolithiasis.

Authors:  L Lee Hamm; Kathleen S Hering-Smith
Journal:  Endocrinol Metab Clin North Am       Date:  2002-12       Impact factor: 4.741

2.  Alkali action on the urinary crystallization of calcium salts: contrasting responses to sodium citrate and potassium citrate.

Authors:  G M Preminger; K Sakhaee; C Y Pak
Journal:  J Urol       Date:  1988-02       Impact factor: 7.450

3.  The efficacy of potassium citrate based medical prophylaxis for preventing upper urinary tract calculi: a midterm followup study.

Authors:  Y H Lee; W C Huang; J Y Tsai; J K Huang
Journal:  J Urol       Date:  1999-05       Impact factor: 7.450

Review 4.  Management of primary hyperoxaluria: efficacy of oral citrate administration.

Authors:  E Leumann; B Hoppe; T Neuhaus
Journal:  Pediatr Nephrol       Date:  1993-04       Impact factor: 3.714

5.  Urinary citrate excretion in patients with renal calculi.

Authors:  M Menon; C J Mahle
Journal:  J Urol       Date:  1983-06       Impact factor: 7.450

6.  Low urinary citrate excretion in nephrolithiasis.

Authors:  M J Nicar; C Skurla; K Sakhaee; C Y Pak
Journal:  Urology       Date:  1983-01       Impact factor: 2.649

7.  Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis.

Authors:  P Barcelo; O Wuhl; E Servitge; A Rousaud; C Y Pak
Journal:  J Urol       Date:  1993-12       Impact factor: 7.450

8.  Idiopathic hypocitraturic calcium-oxalate nephrolithiasis successfully treated with potassium citrate.

Authors:  C Y Pak; C Fuller
Journal:  Ann Intern Med       Date:  1986-01       Impact factor: 25.391

Review 9.  Citrate excretion: a window on renal metabolism.

Authors:  D P Simpson
Journal:  Am J Physiol       Date:  1983-03

10.  Long-term effects of potassium citrate therapy on the formation of new stones in groups of recurrent stone formers with hypocitraturia.

Authors:  N A Whalley; A M Meyers; M Martins; L P Margolius
Journal:  Br J Urol       Date:  1996-07
View more
  3 in total

1.  Hypocitraturia: pathophysiology and medical management.

Authors:  Jack M Zuckerman; Dean G Assimos
Journal:  Rev Urol       Date:  2009

Review 2.  Medical and alternative therapies in urinary tract stone disease.

Authors:  Ercan Yuvanc; Erdal Yilmaz; Devrim Tuglu; Ertan Batislam
Journal:  World J Nephrol       Date:  2015-11-06

3.  Prospective randomized clinical trial comparing phytotherapy with potassium citrate in management of minimal burden (≤8 mm) nephrolithiasis.

Authors:  Iqbal Singh; Ishu Bishnoi; Vivek Agarwal; Shuchi Bhatt
Journal:  Urol Ann       Date:  2011-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.